Eli Lilly Message Board - Msg: 32864512

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,042

-1.2%

Dec 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Moonray	8/3/2020 9:37:14 AM
	of 642

More: Eli Lilly launches late-stage antibody treatment trial to be tested in US nursing homes In many ways, America's nursing homes have become the front lines of the coronavirus pandemic, as the facilities are linked to about 40% of COVID-19 deaths. "In other words, if we give it to an individual, we're testing to see whether they're now protected from getting infected with the virus," Skovronsky added. Eli Lilly is planning to enroll about 2,400 residents and staff of long-term care facilities in its treatment plan. The study, called BLAZE-2 study, is being conducted in partnership with NIAID, part of the National Institutes of Health (NIH). If the late-stage study goes according to plan, Eli Lilly said it could have results by fall. More at: abcnews.go.com o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next